Key facts
- Shaperon’s last known valuation is $16.0M (Feb 2023).
- It has raised $8.8M; the latest was Later Stage VC ($4.7M) in Jan 2026.
- Notable investors include Nissay Capital, BEENEXT Capital Management, AGS Consulting, Cygames Capital, I-nest Capital — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Shaperon
- ·The full record, as it builds
Funding rounds
No funding rounds for Shaperon are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Shaperon
Developer of a messaging platform designed for effective communication with healthcare professionals. The company's platform facilitates digital interactions with medical personnel, allows efficient customer management, integrates with email services to streamline email transmission and reception, and provides file browsing history tracking to support life science organizations in managing promotions and enhancing risk management practices, enabling healthcare companies to govern promotions and strengthen risk management.
- Sector
- Healthcare
- HQ
- Tokyo, Japan
- Founded
- 2017
- Employees
- 20
- Website
- shaperon-inc.com/
- Ownership
- Privately Held (backing)
Shaperon doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Shaperon shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Shaperon in its N-PORT filings yet. We sweep new filings monthly.